Syneron Introduces PicoWay Resolve
Syneron Medical Ltd. introduced the PicoWay Resolve™, a dual wavelength fractional modality for the PicoWay picosecond laser, at the 24th European Academy of Dermatology and Venereology (EADV) Congress in Copenhagen, Denmark, October 7-11, 2015. The launch of the new Resolve fractional picosecond modality, which features both 532nm and 1064nm wavelengths, comes less than a year after the November 2014 launch of the PicoWay platform.
PicoWay utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. PicoWay delivers the shortest picosecond pulses and the highest peak power of any picosecond device on the market.
Resolve employs a holographic fractionator to deliver precisely consistent energy to the entire treatment area, which results in pristine, reproducible results. Resolve's two wavelengths enable treatment of shallow lesions with the 532nm wavelength, while the 1064nm wavelength is used for deeper lesions and to treat all skin types, with no downtime.